Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, and demonstrates an increasing industry focus on the global … Continue reading Creavo Medical Technologies secures U.S. FDA 510(k)
Our CEO, Steve Parker, was interviewed for a feature in this October’s CEO Magazine, where he discussed our device and its potentially game-changing technology. With Steve’s vast experience in the medtech industry, it makes for an interesting read. Take a look at the online version here.
Creavo will be attending the European Society for Emergency Medicine in Athens from 24 – 27 September. Come and visit us on stand H11, we would love to hear from you!
Our Chief Scientific Officer, Professor Ben Varcoe, has written a blog on HuffPost about how our device uses magnetocardiography to help rule out cardiac conditions in chest pain patients, helping to combat the volume of them put through the lengthy A&E triage process. Click here to find out more.
Creavo will be attending the European Society of Cardiology in Barcelona from 26 – 30 August. Come and visit us on stand H650, we would love to hear from you!
We recently spoke to medical news website, Building Better Healthcare, about Vitalscan and how its technology has the potential to revolutionise the treatment of chest pain patients in A&E departments. Read more here.